LRRK2 and Parkinson disease: iPSC-derived astrocytes from PD patients harboring a LRRK2 GS2019S mutation, also tend to accumulate monomeric forms of α-syn, correlating with an impairment of both the CMA and macroautophagy pathways (Figure 1A) [76,107].